Skip to main content

Featured

New Tensions Rise as Iran Warns of Possible Strikes on Regional Energy Sites

  Iran has issued a sharp warning that it may target regional energy infrastructure following recent threats from U.S. President Donald Trump over the Strait of Hormuz. The exchange marks a renewed escalation in a long‑running standoff over one of the world’s most critical maritime chokepoints. According to Iranian officials, any attempt to restrict Tehran’s access to the strait would be met with what they described as “direct and proportional” action. Energy facilities across the Gulf—central to global oil and gas supply—were specifically mentioned as potential targets if tensions continue to rise. The Trump administration has repeatedly criticized Iran’s activities in the region, warning of consequences should Tehran interfere with international shipping. The latest remarks from Washington prompted Iran’s response, which framed its position as defensive and tied to national sovereignty. Regional governments have expressed concern that even rhetorical escalation could unsettle...
Post a Comment
Read more

article

Labels

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Labels:

Comments

Post a Comment